'Dose combination' presentation slideshows

WHO workshop on Quality, good manufacturing practice and bioequivalence with a focus on antituberculotics Jiaxing, China

WHO workshop on Quality, good manufacturing practice and bioequivalence with a focus on antituberculotics Jiaxing, China 5 to 9 November 2007. Finished Pharmaceutical Products (FPPs). Theo Dekker, D.Sc. Research Institute for Industrial Pharmacy

677 views • 51 slides

Contraceptives

783 views • 28 slides

Program Goals

Program Goals. Comparison of Incretin-based Agents. Available FDA-Approved GLP-1 Receptor Agonists. GLP-1 Receptor Agonists: Side Effects and Precautions. Reasons for Initiating Insulin Therapy . AACE Glycemic Control Algorithm.

396 views • 17 slides

Global Drug Facility: Providing Access to Medicines and Commodities for Tuberculosis

Global Drug Facility: Providing Access to Medicines and Commodities for Tuberculosis . Thomas Moore Manager GDF Geneva, 19 November 2009. Structure. Affiliated with Stop TB Partnership, housed at WHO One stop access to medicines, commodities Free grants - fill TB program gaps

265 views • 12 slides

Ledipasvir-Sofosbuvir +/- Ribavirin for 8 or 12 weeks in HCV GT1 ION-3

194 views • 7 slides